Crawford Investment Counsel’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Sell
817
-53
-6% -$19.7K 0.01% 279
2026
Q1
$255K Buy
+870
New +$286K ﹤0.01% 284
2025
Q4
Sell
-802
Closed -$259K 306
2025
Q3
$259K Buy
802
+73
+10% +$22.7K ﹤0.01% 283
2025
Q2
$284K Buy
+729
New +$293K 0.01% 272
2023
Q2
Sell
-640
Closed -$294K 275
2023
Q1
$294K Buy
+640
New +$305K 0.01% 253

Other funds holding ELV

Crawford Investment Counsel's ELV Position: Q2 2026 in Review

Crawford Investment Counsel reduced its Elevance Health (ELV) stake by 6.1% in Q2 2026, selling an estimated $19.7K and leaving 817 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #279.

Crawford Investment Counsel first reported a position in ELV in Q1 2023 and has held it in 5 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Crawford Investment Counsel held 817 shares of Elevance Health worth $316K as of Q2 2026.
  • Crawford Investment Counsel sold 53 Elevance Health shares in Q2 2026, an estimated $19.7K.
  • Elevance Health made up 0.01% of Crawford Investment Counsel's portfolio in Q2 2026, its #279 holding.
  • Crawford Investment Counsel first reported a position in Elevance Health in Q1 2023 and has held it in 5 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Crawford Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.